156 unknown, 51 completed, 38 recruiting, 20 not yet recruiting. 72 Not applicable, 60 Phase 2, 36 Phase 4, 35 Phase 3, 20 Phase 1.
Follow Third Affiliated Hospital, Sun Yat-Sen University: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of iPSC-Derived Motor Neuron Cells (XS228) in Subacute Spinal Cord Injury: A Phase II Randomized Controlled Trial Allogeneic Human Induced Pluripotent Stem Cell (iPSC)-Derived Motor Neuron Progenitor Cells, Placebo - Spinal Cord Injury, Safety | Phase 2 | Not yet recruiting | XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. | 60 | 2028-05-25 | 2025-11-25 |
| Anti-PCSK9 Antibody Tafolecimab and Anti-PD-1 Antibody Sintilimab Combined With Neoadjuvant Chemoradiotherapy for pMMR/ MSS Locally Advanced Rectal Cancer : A Prospective, Multicenter, Randomized, Open-Label, Parallel-Controlled Trial Short-course radiotherapy, CAPOX (oxaliplatin/capecitabine), Sintilimab - Local Advanced Rectal Cancer, PD-1 Inhibitor | Phase 3 | Not yet recruiting | Guangdong Provincial People's Hospital | 148 | 2027-01-01 | 2026-07-07 |
| Clinical Evaluation of a Novel DAB Chromogenic Tissue-Based Assay for Detecting Anti-GABABR Antibodies Autoimmune Encephalitis, Anti-NMDAR Encephalitis | Not yet recruiting | Third Affiliated Hospital, Sun Yat-Sen University | 300 | 2026-10-01 | 2026-10-05 | |
| Very Low-volume Plasma Exchange in ACLF Double Plasma Molecular Adsorption System (DPMAS), Low-volume plasma exchange, Prothrombin Complex Concentrate (PCC) - Acute on Chronic Liver Failure (ACLF) | Not applicable | Not yet recruiting | Third Affiliated Hospital, Sun Yat-Sen University | 840 | 2026-10-01 | 2026-10-05 |
| Liver Stiffness Changes by iLivTouch to Predict Liver-Related Events in MAFLD MAFLD | Not yet recruiting | Beijing Friendship Hospital | 2303 | 2026-09-17 | 2026-08-20 | |
| Autologous Circulating Extracellular Vesicles for Total-Type Sudden Sensorineural Hearing Loss autologous circulating extracellular vesicles, Glucocorticoids - Sudden Sensorineural Hearing Loss (SSNHL) | Phase 3 | Not yet recruiting | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 146 | 2026-09-15 | 2026-10-16 |
| Targeted Therapies for Immunological Non-Responders in People With HIV: A Multicenter Clinical Study cART + Rilpivirine, cART - Immunological Non-Responders in People With HIV | Phase 2 | Recruiting | Beijing 302 Hospital | 21 | 2026-06-15 | 2026-09-24 |
| Real-World Study of Woven EndoBridge for Intracranial Aneurysm Treatment Intrasaccular Flow Disruption Device - Intracranial Aneurysm | Recruiting | Xuanwu Hospital, Beijing | 1000 | 2026-06-10 | 2026-06-11 | |
| Multicenter Registry Study of Patients With Intracranial Dural Arteriovenous Fistulas in China endovascular - Intracranial Dural Arteriovenous Fistula | Recruiting | Xuanwu Hospital, Beijing | 10050 | 2026-05-18 | 2026-06-04 | |
| Low-Dose Bevacizumab and Atezolizumab Combined With TACE-HAIC in Unresectable Hepatocellular Carcinoma TACE-HAIC + Atezolizumab + Low-dose Bevacizumab - Hepatocellular Carcinoma, Atezolizumab Plus Bevacizumab | Not applicable | Not yet recruiting | Third Affiliated Hospital, Sun Yat-Sen University | 38 | 2026-05-01 | 2026-04-22 |
| Efficacy and Safety of Low-dose Bevacizumab Plus Adebrelimab Combined With Transarterial Chemoembolization Followed by Hepatic Arterial Infusion Chemotherapy (TACE-HAIC) as First-line Treatment for Unresectable Hepatocellular Carcinoma: A Single-arm Phase 2 Trial Transarterial Chemoembolization (TACE), Hepatic Arterial Infusion Chemotherapy (HAIC, FOLFOX), Adebrelimab - Adebrelimab (SHR-1316), Bevacizumab | Phase 2 | Not yet recruiting | Third Affiliated Hospital, Sun Yat-Sen University | 38 | 2026-04-10 | 2026-04-28 |
| Clinical Characteristics of Recompensation Cirrhosis, Alcohol Related Liver Disease | Active not recruiting | Third Affiliated Hospital, Sun Yat-Sen University | 300 | 2026-03-31 | 2026-06-16 | |
| Optimizing Endoscopic and Interventional Treatment for Portal Hypertensive Bleeding Portal Hypertension, Gastroesophageal Varices Hemorrhage | Not yet recruiting | Shanghai Zhongshan Hospital | 1066 | 2026-03-17 | 2026-03-31 | |
| Effect of Tegileridine on Postoperative Bowel Function Recovery in Abdominal Surgery Tegileridine, Morphine - Pain, Postoperative, Postoperative Ileus | Phase 4 | Recruiting | Xiangya Hospital of Central South University | 152 | 2026-02-24 | 2026-08-17 |
| Mapping of the Developmental Atlas of the Visual System and Research on Embryonic Neurogenesis Phenomena Tissue collection and multi-omics sequencing analysis - Embryonic Development, Retinal Anomalies | Recruiting | Sheng Liu | 200 | 2026-01-16 | 2026-07-07 | |
| Transarterial Chemoembolization With Low-Dose Bevacizumab Plus Atezolizumab as First-Line Treatment for Unresectable Hepatocellular Carcinoma Transarterial chemoembolization (TACE), bevacizumab and atezolizumab - Hepatocellular Carcinoma, Transarterial Chemoembolization | Not applicable | Not yet recruiting | Third Affiliated Hospital, Sun Yat-Sen University | 30 | 2026-01-01 | 2025-12-15 |
| PT-MSCs Exosome Injection in the Treatment of Chronic-to-acute Liver Failure exosome injection, standard comprehensive internal medical treatment, - Acute-on-Chronic Liver Failure (ACLF) | Early Phase 1 | Active not recruiting | Third Affiliated Hospital, Sun Yat-Sen University | 20 | 2026-01-01 | 2026-02-13 |
| Effectiveness of a Virtual Health Management Community (VHMC) for Pre-diabetes in China Usual Care, VHMC-based Group Interaction Management - Prediabetes | Not applicable | Not yet recruiting | Third Affiliated Hospital, Sun Yat-Sen University | 146 | 2025-12-30 | 2026-01-14 |
| Establishing a Virtual Health Community Management Model for Pre-Diabetes Patients Pre-diabetes Virtual Community - Prediabetes | Not applicable | Completed | Third Affiliated Hospital, Sun Yat-Sen University | 60 | 2025-12-22 | 2026-02-12 |
| Irreversible Electroporation for Recurrent or Metastatic Cervical Lymph Node Metastases From Thyroid Cancer: A Prospective Multicenter Single-Arm Study Irreversible Electroporation (IRE) Ablation - Thyroid Cancer Patients, Lymph Node Metastasis | Not applicable | Recruiting | Tian'an Jiang | 85 | 2025-12-17 | 2026-07-23 |
Showing 20 of 279. Sign in to see all of them.
Hepatitis B, Chronic (31) · Carcinoma, Hepatocellular (22) · Hepatitis B (18) · Acute-On-Chronic Liver Failure (13) · Liver Cirrhosis (11) · Leukemia, Myeloid, Acute (7) · Urinary Bladder Neoplasms (7) · Hematologic Diseases (6) · Hepatitis C, Chronic (6) · Liver Failure (6) · Neuromyelitis Optica (6) · Spinal Cord Injuries (6) · Diabetes Mellitus, Type 2 (5) · Disease (5) · Fibrosis (5)
Tenofovir (12) · peginterferon alfa-2a (11) · Busulfan (10) · Cyclophosphamide (9) · entecavir (8) · peginterferon alfa-2b (7) · tenofovir alafenamide (6) · Bevacizumab (5) · Decitabine (5) · Sorafenib (4) · sintilimab (4) · Etoposide (3) · Metformin (3) · Neoadjuvant Therapy (3) · Ribavirin (3)
China (239) · United Kingdom (1)
Qifa Liu (20) · Liang Peng, Doctor (17) · Qifa Liu, MD (8) · Jian Huang, MD (7) · Limin Rong, M.D. (4) · Cheng Wang, Director (3) · Zhiliang Gao, Doctor (3) · Gao Zhiliang, Doctor (2) · Hongbo Wei, Ph.D (2) · Jiming Zhang, MD (2) · Limin Rong, prof and M.D (2) · Ming Shi, MD (2) · Qifa Liu, MD. (2) · Qiran Zhang, MD (2) · Shuzhong Cui, M.D (2)
PMID 40390028, PMID 10027821, PMID 10857967, PMID 11522720, PMID 12865912, PMID 15078674, PMID 15470215, PMID 15749627, PMID 16638802, PMID 16681561, PMID 17018133, PMID 17896294, PMID 18092326, PMID 18404143, PMID 19064853, PMID 19242495, PMID 19752302, PMID 19918922, PMID 20082624, PMID 20936945, PMID 20970870, PMID 21813293, PMID 23641043, PMID 23670100, PMID 24892406, PMID 24937670, PMID 25199960, PMID 25259922, PMID 25690170, PMID 25965575, PMID 26509605, PMID 26579733, PMID 26919435, PMID 27138577, PMID 27217525, PMID 27575023, PMID 28490871, PMID 28567369, PMID 28847867, PMID 28851800, PMID 28859622, PMID 29303469, PMID 29539639, PMID 29794089, PMID 29854349, PMID 29862225, PMID 30115967, PMID 30258442, PMID 30261643, PMID 30863450